These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 450039)

  • 1. US drug companies push for changes in recombinant DNA guidelines.
    Dickson D
    Nature; 1979 Mar; 278(5703):385-6. PubMed ID: 450039
    [No Abstract]   [Full Text] [Related]  

  • 2. US expected to exempt most recombinant DNA experiments from federal regulation.
    Nature; 1979 Sep; 281(5727):90. PubMed ID: 471066
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant DNA committee.
    Ahmed AK
    Science; 1984 Feb; 223(4635):440. PubMed ID: 6691155
    [No Abstract]   [Full Text] [Related]  

  • 4. US to increase public participation in regulation of DNA research.
    Dickson D
    Nature; 1978 Nov; 276(5687):430. PubMed ID: 723919
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
    Talbot B
    Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
    [No Abstract]   [Full Text] [Related]  

  • 6. Corporate responsibility for recombinant DNA activities.
    Berger BA
    Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
    [No Abstract]   [Full Text] [Related]  

  • 7. The revised "Points to Consider" document.
    Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant DNA research: the scope and limits of regulation.
    Krimsky S; Ozonoff D
    Am J Public Health; 1979 Dec; 69(12):1252-9. PubMed ID: 507257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAC's review of gene therapy: it's time to move on.
    Post LE
    Hum Gene Ther; 1994 Nov; 5(11):1311-2; discussion 1313-4. PubMed ID: 7893802
    [No Abstract]   [Full Text] [Related]  

  • 10. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
    Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
    [No Abstract]   [Full Text] [Related]  

  • 11. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 12. US extends recombinant DNA controls to private industry.
    Dickson D
    Nature; 1978 Dec 21-28; 276(5690):744. PubMed ID: 723950
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA guidelines for further attenuation.
    Dickson D
    Nature; 1981 Mar; 290(5804):281. PubMed ID: 7207619
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes ahead for gene therapy review process?
    Palca J
    Science; 1991 Aug; 253(5020):624-5. PubMed ID: 1871599
    [No Abstract]   [Full Text] [Related]  

  • 15. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the Recombinant Advisory Committee.
    Johnson IS
    Science; 1984 Apr; 224(4646):243. PubMed ID: 6710142
    [No Abstract]   [Full Text] [Related]  

  • 17. NIH/FDA dispute likely to delay research.
    Beardsley T
    Nature; 1985 Aug 15-21; 316(6029):567. PubMed ID: 4033753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH to review policy of DNA committee.
    Culliton BJ
    Science; 1984 Jan; 223(4631):35. PubMed ID: 6691133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Points to Consider Subcommittee. Minutes of meeting, March 31, 1989.
    Recomb DNA Tech Bull; 1989 Sep; 12(3):151-70. PubMed ID: 2595016
    [No Abstract]   [Full Text] [Related]  

  • 20. U.S. moves to require disclosure of gene tests.
    Stolberg SG
    N Y Times Web; 1999 Oct; ():A9. PubMed ID: 11648138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.